Literature DB >> 2200621

Familial acromegaly: studies in three families.

M I McCarthy1, K Noonan, J A Wass, J P Monson.   

Abstract

Acromegaly is usually regarded as a disease which arises sporadically except on those rare occasions in which it occurs as one component of an inherited pluriglandular syndrome. Familial acromegaly occurring in isolation has been reported only rarely. We have studied three families in each of which two first-degree relatives have developed acromegaly without clinical evidence of other endocrinopathies, in order to clarify the relationship of familial acromegaly to multiple endocrine neoplasia, type 1 (MEN 1). No further subclinical cases of acromegaly have been detected in those first-degree relatives of the index cases who were screened. In two of the families, we have found no evidence of abnormal pancreatic or parathyroid function either in the acromegalic index cases or their asymptomatic relatives: a diagnosis of MEN 1 is therefore effectively excluded. In the third family, the presence of multiple subcutaneous lipomata in several members of the family and elevation of PTH levels in two (normocalcaemic) acromegalic index cases, might indicate a highly atypical presentation of MEN 1. None of the six acromegalic index cases had elevations of circulating growth hormone releasing hormone levels. We conclude that isolated familial acromegaly may be more common than has hitherto been realized and that, in these families at least, ectopic production of growth hormone releasing hormone is not responsible.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200621     DOI: 10.1111/j.1365-2265.1990.tb00918.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  13 in total

1.  Isolated familial somatotropinoma.

Authors:  Beatriz Santana Soares; Lawrence A Frohman
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 2.  Familial acromegaly: case report and review of the literature.

Authors:  A Verloes; A Stevenaert; B T Teh; P Petrossians; A Beckers
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

Review 3.  Epidemiology of acromegaly.

Authors:  I M Holdaway; C Rajasoorya
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

Review 4.  Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors.

Authors:  Anelia Horvath; Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

5.  Advances in the Diagnosis, Treatment, and Molecular Genetics of Pituitary Adenomas in Childhood.

Authors:  Margaret F Keil; Constantine A Stratakis
Journal:  US Endocrinol       Date:  2009-02-01

Review 6.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

Review 7.  Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics.

Authors:  Margaret F Keil; Constantine A Stratakis
Journal:  Expert Rev Neurother       Date:  2008-04       Impact factor: 4.618

Review 8.  Pharmacological therapy for acromegaly: a critical review.

Authors:  Alex F Muller; Aart Jan Van Der Lely
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Silent familial isolated pituitary adenomas: histopathological and clinical case report.

Authors:  C Villa; F Magri; P Morbini; A Falchetti; P Scagnelli; E Lovati; D Locatelli; F R Canevari; V Necchi; E Gabellieri; G Guabello; L Chiovato; E Solcia
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

10.  Isolated familial somatotropinomas: clinical features and analysis of the MEN1 gene.

Authors:  Ernesto De Menis; Toni R Prezant
Journal:  Pituitary       Date:  2002-01       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.